Patents by Inventor Keita Nagai

Keita Nagai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220251815
    Abstract: A toilet management system includes a toilet bowl device installed in a toilet room, a management device configured to manage a use situation of the toilet bowl device, and a communication device configured to transmit use situation information related to the use situation of the toilet bowl device to the management device. The management device includes an acquirer configured to acquire the use situation information from the communication device, and an abnormality detector configured to detect an abnormality of the toilet bowl device or a facility or equipment installed inside or around the toilet room when the use situation information acquired by the acquirer matches a predetermined condition.
    Type: Application
    Filed: February 28, 2022
    Publication date: August 11, 2022
    Applicant: LIXIL Corporation
    Inventors: Makoto SARUTA, Shoji OGAWA, Hiroki SHIGETOMO, Hideyuki IDA, Rina NAGAI, Keita MATSUDATE, Misaki NAGATA, Sadaaki SHICHINO, Toshiki HASHIDA
  • Patent number: 11412140
    Abstract: An electronic device comprising: a line-of-sight detection unit configured to receive line-of-sight input from a user and detect a viewed position of the user; an acquisition unit configured to acquire first distance information that corresponds to a distance to an eye of the user; and a control unit configured to 1) set determination time based on the first distance information, and 2) determine that gaze has occurred, in a case where determination is made that the viewed position does not continuously change longer than the determination time.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: August 9, 2022
    Assignee: Canon Kabushiki Kaisha
    Inventor: Keita Nagai
  • Publication number: 20210368100
    Abstract: An electronic device comprising: a line-of-sight detection unit configured to receive line-of-sight input from a user and detect a viewed position of the user; an acquisition unit configured to acquire first distance information that corresponds to a distance to an eye of the user; and a control unit configured to 1) set determination time based on the first distance information, and 2) determine that gaze has occurred, in a case where determination is made that the viewed position does not continuously change longer than the determination time.
    Type: Application
    Filed: May 18, 2021
    Publication date: November 25, 2021
    Inventor: Keita Nagai
  • Patent number: 11084792
    Abstract: The present invention provides a method for producing a difluoromethylene compound and an intermediate thereof, which are useful in the field of pharmaceuticals. Specifically provided is a method for producing a difluoromethylene compound, including a step of allowing a compound represented by formula (6): [wherein L1 represents a halogen atom, a cyano group, a lower alkyl group, a halo-lower alkyl group, a cycloalkyl group, a lower alkoxy group, a halo-lower alkoxy group, or a hydroxy lower alkyl group; R1 represents a lower alkyl group, a halogen atom, a halo-lower alkyl group, a cycloalkyl group, a cyano group, or a hydroxy lower alkyl group; and W represents a nitrogen atom or a methine group] to react with a compound represented by formula (7): [wherein R2 represents a lower alkyl group, a halo-lower alkyl group, a cycloalkyl group, a lower alkenyl group, or an aralkyl group; and R3 represents a chlorine atom, a bromine atom, or an iodine atom].
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: August 10, 2021
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Toshihiko Ozaki
  • Publication number: 20200190038
    Abstract: The present invention provides a method for producing a difluoromethylene compound and an intermediate thereof, which are useful in the field of pharmaceuticals. Specifically provided is a method for producing a difluoromethylene compound, including a step of allowing a compound represented by formula (6): [wherein L1 represents a halogen atom, a cyano group, a lower alkyl group, a halo-lower alkyl group, a cycloalkyl group, a lower alkoxy group, a halo-lower alkoxy group, or a hydroxy lower alkyl group; R1 represents a lower alkyl group, a halogen atom, a halo-lower alkyl group, a cycloalkyl group, a cyano group, or a hydroxy lower alkyl group; and W represents a nitrogen atom or a methine group] to react with a compound represented by formula (7): [wherein R2 represents a lower alkyl group, a halo-lower alkyl group, a cycloalkyl group, a lower alkenyl group, or an aralkyl group; and R3 represents a chlorine atom, a bromine atom, or an iodine atom].
    Type: Application
    Filed: April 27, 2018
    Publication date: June 18, 2020
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita NAGAI, Toshihiko OZAKI
  • Patent number: 9876960
    Abstract: An image pickup apparatus which is capable of shortening a time period required for photometric measurement and obtaining an accurate photometric measurement value when there has been a shift from a photometric measurement operation using an image pickup device to a photometric measurement operation using a linear photometric sensor. When there has been no shift from a photometric measurement operation by the image pickup device to a photometric measurement operation by the photometric sensor, the photometric sensor performs a first photometric measurement operation for a plurality of times, and when there has been a shift from a photometric measurement operation by the image pickup device to a photometric measurement operation by the photometric sensor, a second photometric measurement operation is performed for a smaller number of times than that of the first photometric measurement operation according to a result of photometric measurement performed by the image pickup device.
    Type: Grant
    Filed: June 9, 2016
    Date of Patent: January 23, 2018
    Assignee: Canon Kabushiki Kaisha
    Inventor: Keita Nagai
  • Patent number: 9650380
    Abstract: A compound having an URAT1 inhibitory activity, and an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: May 16, 2017
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Motoaki Baba, Shinichi Fujioka, Koh Nagasawa, Hirobumi Takahashi, Eri Kondoh, Sachie Sogo, Kenichi Tanaka, Yoshiki Itoh
  • Patent number: 9648249
    Abstract: An image capturing apparatus comprises an image capturing unit, a calculation unit configured to calculate light amount variation characteristics of light from an object, a photometric value determination unit configured to determine a photometry value used for determination of an exposure condition based on the light amount variation characteristics calculated by the calculation unit, and an exposure condition determination unit configured to determine an exposure condition when performing exposure of the image capturing unit at a timing set based on the light amount variation characteristics calculated by the calculation unit, based on the photometry value determined by the photometric value determination unit.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: May 9, 2017
    Assignee: Canon Kabushiki Kaisha
    Inventors: Atsushi Sugawara, Naoyuki Nakagawara, Keita Nagai
  • Publication number: 20170044158
    Abstract: A compound having an URAT1 inhibitory activity, and an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 16, 2017
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita NAGAI, Motoaki BABA, Shinichi FUJIOKA, Koh NAGASAWA, Hirobumi TAKAHASHI, Eri KONDOH, Sachie SOGO, Kenichi TANAKA, Yoshiki ITOH
  • Publication number: 20160366321
    Abstract: An image pickup apparatus which is capable of shortening a time period required for photometric measurement and obtaining an accurate photometric measurement value when there has been a shift from a photometric measurement operation using an image pickup device to a photometric measurement operation using a linear photometric sensor. When there has been no shift from a photometric measurement operation by the image pickup device to a photometric measurement operation by the photometric sensor, the photometric sensor performs a first photometric measurement operation for a plurality of times, and when there has been a shift from a photometric measurement operation by the image pickup device to a photometric measurement operation by the photometric sensor, a second photometric measurement operation is performed for a smaller number of times than that of the first photometric measurement operation according to a result of photometric measurement performed by the image pickup device.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 15, 2016
    Inventor: Keita Nagai
  • Patent number: 9512119
    Abstract: The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: December 6, 2016
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Motoaki Baba, Shinichi Fujioka, Koh Nagasawa, Hirobumi Takahashi, Eri Kondoh, Sachie Sogo, Kenichi Tanaka, Yoshiki Itoh
  • Patent number: 9359350
    Abstract: The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: June 7, 2016
    Assignee: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Koh Nagasawa, Hirobumi Takahashi, Motoaki Baba, Shinichi Fujioka, Eri Kondoh, Kenichi Tanaka, Yoshiki Itoh
  • Publication number: 20150203490
    Abstract: The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.
    Type: Application
    Filed: February 11, 2015
    Publication date: July 23, 2015
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita NAGAI, Koh NAGASAWA, Hirobumi TAKAHASHI, Motoaki BABA, Shinichi FUJIOKA, Eri KONDOH, Kenichi TANAKA, Yoshiki ITOH
  • Publication number: 20150191463
    Abstract: The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 9, 2015
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Motoaki Baba, Shinichi Fujioka, Koh Nagasawa, Hirobumi Takahashi, Eri Kondoh, Sachie Sogo, Kenichi Tanaka, Yoshiki Itoh
  • Publication number: 20150138392
    Abstract: An image capturing apparatus comprises an image capturing unit, a calculation unit configured to calculate light amount variation characteristics of light from an object, a photometric value determination unit configured to determine a photometry value used for determination of an exposure condition based on the light amount variation characteristics calculated by the calculation unit, and an exposure condition determination unit configured to determine an exposure condition when performing exposure of the image capturing unit at a timing set based on the light amount variation characteristics calculated by the calculation unit, based on the photometry value determined by the photometric value determination unit.
    Type: Application
    Filed: November 13, 2014
    Publication date: May 21, 2015
    Inventors: Atsushi Sugawara, Naoyuki Nakagawara, Keita Nagai
  • Patent number: 8987473
    Abstract: The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: March 24, 2015
    Assignee: Sato Pharmaceutical Co., Ltd.
    Inventors: Keita Nagai, Koh Nagasawa, Hirobumi Takahashi, Motoaki Baba, Shinichi Fujioka, Eri Kondoh, Kenichi Tanaka, Yoshiki Itoh
  • Publication number: 20140005221
    Abstract: The present invention relates to a compound that has URAT1 inhibitory action, and a URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition comprising the compound. More specifically, the present invention relates to a compound represented by Formula (I) below.
    Type: Application
    Filed: January 30, 2012
    Publication date: January 2, 2014
    Applicant: SATO PHARMACEUTICAL CO., LTD.
    Inventors: Keita Nagai, Koh Nagasawa, Hirobumi Takahashi, Motoaki Baba, Shinichi Fujioka, Eri Kondoh, Kenichi Tanaka, Yoshiki Itoh
  • Patent number: 8101621
    Abstract: The present invention relates to a compound of general formula I: wherein: n1 and n2 are the same or different, and are 0 or 1; R is aryl, heteroaryl, etc.; Re is hydrogen atom or lower alkyl; two groups selected from four groups consisting of (i) either one of Ra1 and Ra1?, (ii) either one of Ra2 and Ra2?, (iii) either one of Rb1 and Rb1?, and (iv) either one of Rb2 and Rb2?, are combined to form —(CH2)n— where n is 1, 2 or 3; and among Ra1, Ra1?, Ra2, Ra2?, Rb1, Rb1?, Rb2 and Rb2?, the groups which do not form —(CH2)n— are each independently hydrogen atom, etc.; X1, X2, X3 and X4 are each independently CH, N, etc.; Y1, Y2, Y3 and Y4 are the same or different and are CH or N, etc.; W is a 5-membered aromatic heterocyclic group, or a pharmaceutically acceptable salt or ester thereof.
    Type: Grant
    Filed: April 25, 2007
    Date of Patent: January 24, 2012
    Assignee: MSD K.K.
    Inventors: Tetsuya Kato, Nobuhiko Kawanishi, Takashi Mita, Keita Nagai, Katsumasa Nonoshita, Mitsuru Ohkubo
  • Publication number: 20090192174
    Abstract: The present invention relates to a compound of general formula I: wherein: n1 and n2 are the same or different, and are 0 or 1; R is aryl, heteroaryl, etc.; Re is hydrogen atom or lower alkyl; two groups selected from four groups consisting of (i) either one of Ra1 and Ra1?, (ii) either one of Ra2 and Ra2?, (iii) either one of Rb1 and Rb1?, and (iv) either one of Rb2 and Rb2?, are combined to form —(CH2)n— where n is 1, 2 or 3; and among Ra1, Ra1?, Ra2, Ra2?, Rb1, Rb1?, Rb2 and Rb2?, the groups which do not form —(CH2)n— are each independently hydrogen atom, etc.; X1, X2, X3 and X4 are each independently CH, N, etc.; Y1, Y2, Y3 and Y4 are the same or different and are CH or N, etc.; W is a 5-membered aromatic heterocyclic group, or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: April 25, 2007
    Publication date: July 30, 2009
    Applicant: BANYU PHARMACEUTICAL CO., LTD.
    Inventors: Tetsuya Kato, Nobuhiko Kawanishi, Takashi Mita, Keita Nagai, Katsumasa Nonoshita, Mitsuru Ohkubo
  • Patent number: 7482358
    Abstract: Compounds represented by the general formula (I): wherein Ar1 and Ar2 are each aryl or heteroaryl; R1 is lower cycloalkyl, —Ar3, or a group of the general formula (a), (b) or (c): and R2 and R3are each hydrogen, lower cycloalkyl, lower alkenyl, or optionally substituted lower alkyl (with the proviso that when R2 and R3 are simultaneously hydrogen, Ar1, Ar2 and R1 do not simultaneously represent unsubstituted phenyl).
    Type: Grant
    Filed: February 7, 2006
    Date of Patent: January 27, 2009
    Assignee: Banyu Pharmaceutical Co., Ltd.
    Inventors: Nagaaki Sato, Osamu Okamoto, Makoto Jitsuoka, Keita Nagai, Akio Kanatani, Akane Ishihara, Yasuyuki Ishii, Takehiro Fukami